BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ueno N, Asakawa A, Satoh Y, Inui A. Increased circulating cholecystokinin contributes to anorexia and anxiety behavior in mice overexpressing pancreatic polypeptide. Regul Pept 2007;141:8-11. [PMID: 17306894 DOI: 10.1016/j.regpep.2006.12.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Näslund E, Hellström PM. Drug targets modulating the gut-appetite-metabolism axis. Drug Discovery Today: Therapeutic Strategies 2007;4:189-93. [DOI: 10.1016/j.ddstr.2007.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Giordano C, Marchiò M, Timofeeva E, Biagini G. Neuroactive peptides as putative mediators of antiepileptic ketogenic diets. Front Neurol 2014;5:63. [PMID: 24808888 DOI: 10.3389/fneur.2014.00063] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
3 Kanegawa N, Suzuki C, Ohinata K. Dipeptide Tyr-Leu (YL) exhibits anxiolytic-like activity after oral administration via activating serotonin 5-HT 1A , dopamine D 1 and GABA A receptors in mice. FEBS Letters 2010;584:599-604. [DOI: 10.1016/j.febslet.2009.12.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
4 Morales-Medina JC, Dumont Y, Quirion R. A possible role of neuropeptide Y in depression and stress. Brain Res 2010;1314:194-205. [PMID: 19782662 DOI: 10.1016/j.brainres.2009.09.077] [Cited by in Crossref: 132] [Cited by in F6Publishing: 128] [Article Influence: 10.2] [Reference Citation Analysis]
5 Dumont Y, Morales-medina JC, Quirion R. Neuropeptide Y and its Role in Anxiety-related Disorders. In: Shioda S, Homma I, Kato N, editors. Transmitters and Modulators in Health and Disease. Tokyo: Springer Japan; 2009. pp. 51-82. [DOI: 10.1007/978-4-431-99039-0_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Painsipp E, Wultsch T, Edelsbrunner ME, Tasan RO, Singewald N, Herzog H, Holzer P. Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes Brain Behav 2008;7:532-42. [PMID: 18221379 DOI: 10.1111/j.1601-183X.2008.00389.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
7 Ting CH, Chen YC, Liaw WJ, Lin HC, Chen CY. Peripheral injection of pancreatic polypeptide enhances colonic transit without eliciting anxiety or altering colonic secretion in rats. Neuropeptides. 2016;55:67-71. [PMID: 26601891 DOI: 10.1016/j.npep.2015.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
8 Yamada Y, Muraki A, Oie M, Kanegawa N, Oda A, Sawashi Y, Kaneko K, Yoshikawa M, Goto T, Takahashi N, Kawada T, Ohinata K. Soymorphin-5, a soy-derived μ-opioid peptide, decreases glucose and triglyceride levels through activating adiponectin and PPARα systems in diabetic KKA y mice. American Journal of Physiology-Endocrinology and Metabolism 2012;302:E433-40. [DOI: 10.1152/ajpendo.00161.2011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
9 Hirata H, Sonoda S, Agui S, Yoshida M, Ohinata K, Yoshikawa M. Rubiscolin-6, a δ opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating σ1 and dopamine D1 receptors. Peptides 2007;28:1998-2003. [DOI: 10.1016/j.peptides.2007.07.024] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
10 Tasan RO, Lin S, Hetzenauer A, Singewald N, Herzog H, Sperk G. Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 2009;158:1717-30. [PMID: 19121371 DOI: 10.1016/j.neuroscience.2008.11.048] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
11 Zhao H, Ohinata K, Yoshikawa M. Rubimetide (Met-Arg-Trp) derived from Rubisco exhibits anxiolytic-like activity via the DP1 receptor in male ddY mice. Peptides 2008;29:629-32. [DOI: 10.1016/j.peptides.2007.12.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
12 Holzer P, Reichmann F, Farzi A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides. 2012;46:261-274. [PMID: 22979996 DOI: 10.1016/j.npep.2012.08.005] [Cited by in Crossref: 249] [Cited by in F6Publishing: 222] [Article Influence: 24.9] [Reference Citation Analysis]